Fact CheckerSign in

NCT05859620Active, not recruiting

Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery

Implementation of a Clinical Screening and Response System for the Early Detection of Cardiac Complications After Noncardiac Surgery: Feasibility and Medicoeconomic Impact

Source: ClinicalTrials.gov · Last updated 5 May 2026

Brief summary (registry, in English)

The investigators aim to show the feasibility and medicoeconomic impact of implementing a clinical screening and response system for the early detection of perioperative cardiac complications in high-risk patients. Specifically, the investigators aim to: 1) evaluate the feasibility of implementation of a PMI-screening; 2) evaluate the medicoeconomic impact of implementing a PMI-screening; 3) identify barriers to implementation; 4) generate data for a future randomized controlled trial on outcomes by exploring opportunities to improve care following PMI, the occurrence and timing of major adverse cardiac events (MACE), and the treatment effect associated with PMI-screening.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
900 (estimated)
First submitted
6 Feb 2023
Start date
1 Jul 2021
Primary completion date
Dec 2026
Lead sponsor
University Hospital, Basel, Switzerland
NCT number
NCT05859620

What you commit to

  • Study type: Observational
  • Planned participants: 900
  • From 1 Jul 2021 to the primary completion date, Dec 2026
  • 5 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous inclusion within 5 days

Other illness

  • patients with cardiac surgery or interventions in the last 14 days
  • chronic renal failure under dialysis, renal transplant surgery
  • moderate-to-severe dementia

Other

  • documented refusal to use of their data for research purposes or refusal of further use during follow-up
  • Patients declining consent for follow-up will be excluded from follow-up analyses.

Who the study is looking for

  • Consecutive patients fulfilling the institutional criteria for inclusion into the routine PMI-screening
  • aged 40-85 years
  • at increased cardiovascular risk
  • undergoing inpatient, noncardiac, elective or emergent surgery
  • postoperative stay of ≥2 nights at the participating institution
  • orthopaedic, traumatology, vascular, spinal, thoracic, neurosurgical, and visceral surgery.

Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Innsbruck
Coordinator of this site? Confirm its status
InnsbruckAustriaUnknown status
University Hospital Geneva
Coordinator of this site? Confirm its status
GenevaSwitzerlandUnknown status
Cantonal Hospital Lucerne
Coordinator of this site? Confirm its status
LucerneSwitzerlandUnknown status
Canton Hospital Olten
Coordinator of this site? Confirm its status
OltenSwitzerlandUnknown status
Bürgerspital Solothurn
Coordinator of this site? Confirm its status
SolothurnSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.